Marex Group’s Abbott ABT Stock Holding History

Marex Group’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$883K	Buy	8,601 +6,349	+282%	+$717K	0.01%	468
2025 Q4	$282K	Buy	+2,252	New	+$287K	﹤0.01%	719

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Marex Group's ABT Position: Q1 2026 in Review

Marex Group increased its Abbott (ABT) stake by 282% in Q1 2026, buying an estimated $717K and bringing the position to 8,601 shares worth $883K. The position accounts for 0.01% of the portfolio, ranked #468.

Marex Group first reported a position in ABT in Q4 2025 and has held it in 2 quarters since. 3,085 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Marex Group held 8,601 shares of Abbott worth $883K as of Q1 2026.
Marex Group bought 6,349 Abbott shares in Q1 2026, an estimated $717K.
Abbott made up 0.01% of Marex Group's portfolio in Q1 2026, its #468 holding.
Marex Group first reported a position in Abbott in Q4 2025 and has held it in 2 quarters since.
3,085 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.